Lacosamide-inj-aspiro (Lacosamide Inj Aspiro)
Lacosamide Injection
Product Images NDC 72865-235
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72865-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lacosamide-inj-carton-label-10-mg-ml (Lacosamide Inj Carton Label 10 mg mL)
Packaging label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection by XLCare Pharmaceuticals Inc. Contains 10 single-dose vials of 20 mL each. Label indicates pharmacist instructions, manufacturing and contact details, storage conditions, and inactive ingredients.*
Lacosamide-inj-fig-1 (Lacosamide Inj Fig 1)
A bar graph showing seizure reduction percentages as median percent change from baseline in Study 2, Study 3, and Study 4. The graph compares placebo with different doses of Lacosamide (200, 400, 600 mg/day). Lacosamide groups show higher seizure reduction, with statistically significant differences marked by asterisks compared to placebo.*
Lacosamide-inj-fig-2 (Lacosamide Inj Fig 2)
A responder rate graph displaying the percentage of patients (x-axis) versus responder rate (equal to or greater) indicating improvement or worsening (y-axis) for Placebo and three Lacosamide dosage groups: 200 mg/day, 400 mg/day, and 600 mg/day. The graph uses different line styles to distinguish among the four groups.*
Lacosamide-inj-structure (Lacosamide Inj Structure)
Chemical structure diagram of lacosamide, showing its molecular framework with key functional groups including an acetyl group, methoxy group, amide bonds, and a benzyl group.*
Lacosamide-inj-vial-label-10-mg-ml (Lacosamide Inj Vial Label 10 mg mL)
Label for Lacosamide Injection, USP, 10 mg/mL strength, available as a 20 mL single-dose vial. The label states it is for intravenous use only, manufactured by Aspiro Pharma Limited, India, for XL Care Pharmaceuticals Inc. It includes storage instructions, dosage guidance, and a barcode with the NDC 72865-235-01.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
